Bendit – treatment for lymphoma, leukemia and multiple myeloma

oncology  /  Bendit

Bendit

Bendit is a pharmaceutical drug containing the active substance bendamustine, widely used in oncology for the treatment of various cancers. Bendit is primarily indicated for the therapy of lymphomas,... Bendit is a pharmaceutical drug containing the active substance bendamustine, widely used in oncology for the treatment of various cancers. Bendit is primarily indicated for the therapy of lymphomas, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. The drug functions as an alkylating agent, damaging the DNA of cancer cells and inhibiting their proliferation. Due to its high efficacy and unique mechanism of action, Bendit is often prescribed for patients resistant to other chemotherapy treatments. Treatment with Bendit requires careful medical supervision and is administered under strict monitoring. The medication contributes to improving patient quality of life and increasing survival rates in cancer patients. Read more Hide

• Active ingredient:
  Bendamustine
• Manufacturer: Natco
• Dosage: 100 mg
• Dosage form: Vial
• Units per pack: 1
• Delivery across Ukraine
• 100% original product